venerdì, 30 luglio 2021
Medinews
3 Luglio 2017

FDA Tackles Drug Competition to Improve Patient Access

June 27, 2017 – Today, the U.S. Food and Drug Administration is taking two new, important steps to increase competition in the market for prescription drugs and facilitate entry of lower-cost alternatives. The agency published a list of off-patent, off-exclusivity branded drugs without approved generics, and also implemented, for the first time, a new policy to expedite the review of generic drug applications where competition is limited. These actions are among the first … (leggi tutto)

TORNA INDIETRO